Trademark: 90597184
Word
RAGE TO LIVE
Status Date
Monday, July 1, 2024
Filing Date
Tuesday, March 23, 2021
Published for Opposition
Tuesday, December 7, 2021
Abandoned Date
Monday, July 1, 2024
41 Arranging, organizing, conducting, and hosting social entertainment events; entertainment, namely, production of musical events; organizing cultural and arts events
9 Downloadable podcasts in the field of promoting public interest and awareness of rare diseases; downloadable computer software in the nature of a mobile application to promote public interest and awareness of rare diseases; downloadable computer software for sharing, transmitting, storing, uploading, downloading, sending, and receiving information concerning rare diseases
5 Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of cancer; medicines for human purposes, namely, for treating genetically based diseases and disorders
25 Apparel, namely, tee shirts, sweatshirts, pants, leggings, shorts, jackets, hats and caps; footwear
36 Charitable fundraising services for promoting research, education and other activities relating to cancers and other rare diseases; venture capital fund management and investment services; hedge fund investment services; equity fund investment services; financial analysis; financial planning and investment advisory service; insurance brokerage in the field of medical and health insurance; providing information in the field of finance and the financial aspects of medical and health procedures, treatments, and insurance
35 Promoting collaboration within the scientific, research, medical, and business communities to achieve advances in the field of healthcare; promoting collaboration within the scientific, research, medical provider, and business communities to achieve advances in the field of rare diseases; marketing campaign services in the nature of promoting public awareness among rare disease patients, caregivers, families, advocates, and friends; online retail store services featuring apparel and footwear; public advocacy to promote awareness of rare diseases and cancers; advertising and marketing consultancy; advertising, promotion, and marketing services in the nature of using social and digital media technology to find patients for medical providers and to connect patients to clinical studies; marketing consultation in the field of clinical trials; marketing consulting, namely, developing and monitoring social and digital media advertising campaigns in connection with clinical trials and patients with rare medical conditions; marketing services in the nature of conducting online, phone or in-person patient or physician market research; on-line advertising and marketing services; providing demand creation and lead generation activities and services; providing marketing consulting in the field of social media; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, providing information management services; providing advertising, marketing and promotional services for the pharmaceutical and medical industry; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
45 Online social networking services for patient and caregiver communities
44 Health care services, namely, cancer therapy; providing a web site featuring medical information; providing a website featuring information in the field of the diagnosis and treatment of rare diseases; providing a website featuring information in the field of rare disease health; providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing medical information to patients in the form of reports in the field of medicine and rare diseases; providing news and information in the field of medicine; providing educational information about healthcare
42 Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials; basic and clinical research in the field of health care and medicine; Clinical and medical research, data collection and scientific analysis and communication of results to the pharmaceutical and health care industries in the fields of health, medical care and pharmaceutical efficacy; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; medical and scientific research, namely, conducting clinical trials for others; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease; operating, namely, creating and hosting an online community website relating to patients with rare diseases; pharmaceutical research services, namely, recruitment of rare disease patients for panels such as pharmaceutical research panels; design and development of computer software; platform as a service (PAAS) featuring computer software platforms for clinical trial patient lead management and enrollment; Platform as a service (PAAS) featuring computer software platforms for clinical trials; Platform as a service (PAAS) featuring computer software platforms for patient and physician market research; Platform as a service (PAAS) featuring computer software platforms for education about rare diseases and treatment received
Mar 26, 2021
New Application Entered
Jun 28, 2021
New Application Office Supplied Data Entered
Oct 27, 2021
Assigned To Examiner
Oct 27, 2021
Non-Final Action Written
Oct 27, 2021
Non-Final Action E-Mailed
Oct 27, 2021
Notification Of Non-Final Action E-Mailed
Oct 29, 2021
Teas Response To Office Action Received
Oct 29, 2021
Correspondence Received In Law Office
Oct 30, 2021
Teas/Email Correspondence Entered
Nov 1, 2021
Approved For Pub - Principal Register
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Dec 7, 2021
Published For Opposition
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 6, 2022
Extension Of Time To Oppose Received
Apr 17, 2022
Extension Of Time To Oppose Process - Terminated
May 31, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2022
Sou Teas Extension Received
Nov 29, 2022
Sou Extension 1 Filed
Nov 29, 2022
Sou Extension 1 Granted
Dec 1, 2022
Notice Of Approval Of Extension Request E-Mailed
May 30, 2023
Sou Teas Extension Received
May 30, 2023
Sou Extension 2 Filed
May 30, 2023
Sou Extension 2 Granted
Jun 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2023
Sou Teas Extension Received
Nov 30, 2023
Sou Extension 3 Filed
Nov 30, 2023
Sou Extension 3 Granted
Dec 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 1, 2024
Abandonment - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
